Equilibrium Energy

Equilibrium Energy operates at the intersection of grid variability, electricity markets volatility, economic and asset optimization, commercial structuring, power trading, and risk management, enabling clients to achieve global scale and climate impact and accelerate society's collective path to climate, energy, and societal equilibrium. 

Power Grid Energy Commercial

$33M

Latest Funding

Series A

Latest Funding Stage

2023-08-01

Funding Date

81

Employees

United States

Location

San Francisco, California

City & State

Key Contacts
Unlock Contact Information

Upgrade to access founder details

Upgrade Now
Open Positions
View Careers Page
Hiring For
AI Software Development Engineering Power Systems Quantitative Finance Trading Structuring Finance Operations
Unlock Tech Stack Data

Upgrade to access technology insights

Upgrade Now

Similar Startups

STAX Engineering
STAX Engineering Logo

The STAX mission is to help 1 billion people significantly through new technologies that promote health, sustainability, reduced environmental toxins, and reduced global warming.

CarbonQuest
CarbonQuest Logo

CarbonQuest offers onsite carbon capture, sequestration, and reduction for hospitals and healthcare facilities, government and municipal buildings, and offices, enabling companies to reduce the footprint of carbon-intensive processes.

Flow48
Flow48 Logo

Flow48 is a financial technology company specializing in revenue-based financing solutions for small and medium-sized enterprises. The company's services include invoice-based financing, which accelerates cash flow by unlocking funds tied up in unpaid invoices, and revenue-based financing, providing upfront capital against future earnings.

Stablepharma
Stablepharma Logo

Stablepharma’s technology platform, StablevaX™ converts existing approved vaccines, therapeutics and diagnostics into fridge free thermostable products that do not require refrigeration to preserve them, thereby addressing the global challenges of the cold chain. Stablepharma’s R&D team have identified up to 60 vaccine candidates that could be suitable for StablevaX™ technology.